| Date | Title | Description |
| 18.06.2026 | Neuron23 Receives $2.5 Million Grant From The Michael J. Fox Foundation To Expand Phase 2 Parkinson’s Trial | Neuron23, a clinical-stage biotechnology company developing precision medicines for Parkinson’s disease, announced it received a $2.5 million grant from The Michael J. Fox Foundation for Parkinson’s Research to support the expansion of its ... |
| 25.06.2025 | Neuron23: Pioneering Precision Medicine with a $96.5 Million Boost | In the ever-evolving landscape of biotechnology, Neuron23 stands as a beacon of hope. This San Francisco-based company has just secured $96.5 million in Series D funding, a significant leap forward in its mission to develop precision medici... |
| 25.06.2025 | Neuron23 Raises $96.5M in Series D Financing | Neuron23, a San Francisco, CA-based clinical-stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases, raised $96.5M in Series D funding.
The round wa sled by heal... |
| 24.06.2025 | Neuron23: $96.5 Million Series D Raised For Advancing Neurological And Immunological Medicines | Neuron23 – a clinical-stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases – announced the closing of a $96.5 million Series D funding round led by a healthcar... |
| 08.11.2024 | Axiom Space's Bold Leap: Partnering with India for the Stars | In the ever-expanding universe of space exploration, partnerships are the new rocket fuel. Axiom Space, a U.S.-based startup, is eyeing Indian launch vehicles to bolster its mission to the International Space Station (ISS). This move is not... |
| 06.11.2024 | Speak at the Tech.eu Summit London 2025: be heard by Europe's tech leaders | Speaker applications are now open for the Tech.eu Summit London 2025!
The Summit will take place in London on March 25 - 26 at the Queen Elizabeth II Centre.
It provides a critical means of fostering meaningful connections with Europe's mos... |
| 05.02.2024 | Early-stage UK VC Episode 1 closes $95M third fund | Early stage European venture capital (VC) firm Episode 1 has closed its third fund at £76 million ($95 million), as the London-based investor turns to in-house “data-driven deal sourcing tools” to find the next big thing.
Founded in 2013, E... |
| 05.02.2024 | Estonian Plural leads $11.4M round for UK’s Sano Genetics | Estonian Plural leads $11.4M round for UK’s Sano Genetics
05 February, 2024, 10:51
Mariia Denysiuk --> --> --> -->--> --> --> --> --> --> --> --> -->
Sano Genetics, a Cambridge-based software platfo... |
| 22.01.2024 | Sano Genetics Raises $11.4M in Funding | Sano Genetics, a Cambridge, UK-based provider of a software platform for precision medicine clinical trials, raised $11.4M in funding.
The round, which brought the total amount to $22M, was led by Plural.
The company intends to use the fund... |
| 22.01.2024 | Sano Genetics raises $11.4M to advance precision medicine clinical trials | Precision medicine software platform Sano Genetics announced a $11.4 million raise led by Plural today.
The only software platform tailored to running precision medicine clinical trials, Sano Genetics leverages AI to manage all aspects, fro... |
| 22.01.2024 | Exclusive: Sano Genetics nabs $11.4M for precision medicine trials | Sano Genetics, a software platform to facilitate precision medicine-powered clinical trials, raised $11.4 million in funding, CEO Patrick Short tells Axios exclusively.
Why it matters: AI can make traditional clinical trials — which are ver... |
| 22.01.2024 | Sano Genetics Secures $11.4M to Turbocharge Precision Medicine Research | What You Should Know:
– Sano Genetics, a software company that is revolutionizing precision medicine research, has secured $11.4M in new funding.
– This latest investment, led by Plural with participation from existing investors MMC Venture... |
| 14.12.2023 | Sano Genetics launches ‘Light the Way’ programme for MND | - |
| 21.03.2023 | Parkwalk – Improving Healthcare by Investing in Genomics | To mark the end of Healthcare Science Week, we discuss the value and impact of investing in genomics. We also give examples of some ground-breaking genomic companies Parkwalk has invested in. |
| 29.03.2022 | Sano Genetics lands $11M Series A | Cambridge-based Sano Genetics has raised $11 million in a round led by MMC Ventures. The startup's platform connects patients who have rare, chronic diseases with researchers conducting personalized studies. The funds will be used for recru... |
| 28.03.2022 | UK’s healthtech startup Sano Genetics raises €10M for its personalised treatment research platform | Cambridge, the UK-based Sano Genetics, a personalised medicine research platform that claims to make discoveries and develop personalised treatments quickly and cost-effectively, announced on Monday that it has raised $11M (approximately €1... |
| 28.03.2022 | MMC leads $11 milllion Series A for genetic disease research platform, Sano Genetics | Sano has developed a software platform that connects patients living with rare and chronic conditions, such as Long Covid, multiple sclerosis, Parkinson’s and Alzheimer’s, directly with biotech and pharmacetuical companies leading personali... |
| 28.03.2022 | Cambridge startup snags $11 million to fast-track genetic disease research | Cambridge-based Sano Genetics has raised $11 million funding to build patient-friendly tech. The Series A funding round was led by MMC Ventures, with further funding from Episode 1, Seedcamp and several experienced operators in software and... |
| 28.03.2022 | Sano Genetics raises £8m to connect rare disease patients with medicine providers | Sano Genetics, a startup that has developed a platform to connect patients that have rare, chronic diseases with personalised medicine providers, has raised $11m (£8.4m) in a Series A funding round.
Cambridge-based Sano Genetics will use th... |
| 28.03.2022 | Sano Genetics targets $113bn market after $11m Series A | - |
| 04.02.2022 | Annual #21toWatch announces shortlist in advance of return to in-person awards event | Annual #21toWatch announces shortlist in advance of return to in-person awards event
04-02-2022
Next month’s coveted #21toWatch Awards announces 2022 shortlist, featuring some of the most ground-breaking entrepreneurs, startups and innovati... |
| 04.02.2022 | Annual #21toWatch announces shortlist in advance of return to in-person awards event | Next month’s coveted #21toWatch Awards announces 2022 shortlist, featuring some of the most ground-breaking entrepreneurs, startups and innovations from the East of England.
After presenting the Top21 awards virtually for the last two years... |
| 01.09.2021 | The U.K. Genomics Startups Changing The Future Of Healthcare Forever | Genomics: the future of healthcare getty |
| 26.01.2021 | Cambridge-based Sano Genetics gets a capital injection of £2.5M to offer free at-home DNA testing kits for those affected by Long COVID | Sano Genetics, a Cambridge-based startup with an aim to support personalised medicine research by increasing participation in clinical trials and guiding patients all through the process has recently grabbed £2.5M seed funding from a slew o... |
| 25.01.2021 | Cambridge’s Sano Genetics gets £2.5 million to send at-home genetics tests to ‘Long Covid’ patients | Cambridge’s Sano Genetics has raised £2.5 million in seed funding led by Episode 1 Ventures, alongside Seedcamp, Cambridge Enterprise, January Ventures and some angel investors from Europe and the US.
With this latest investment and a grant... |
| 25.01.2021 | Sano Genetics, a startup helping with Long Covid research, raises £2.5M in seed funding | Sano Genetics, a startup with a broad mission to support personalised medicine research by increasing participation in clinical trials, has raised £2.5 million in seed funding.
The round is led by Episode1 Ventures, alongside Seedcamp, Camb... |
| 19.11.2019 | Hacking the world’s biggest startup event: Slush, Helsinki | At one of the busiest tech conferences in the world, it can be hard to know where to start and what to prioritise as a tech founder. This year Tech Nation will be bringing 10 tech companies from across the country to Helsinki for a chance t... |
| - | Cambridge startup snags $11 million to fast-track genetic disease research | Cambridge-based Sano Genetics has raised $11 million funding to build patient-friendly tech. The Series A funding round was led by MMC Ventures, with further funding from Episode 1, Seedcamp and several experienced operators in software and... |
| - | Sano Genetics | “Sano's end-to-end precision medicine platform de-risks trials, enabling clinical operations teams to move 10x faster and reduce costs by 5x. ” |
